Literature DB >> 18038122

[Amyotrophic lateral sclerosis].

R Gastl1, A C Ludolph.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive, degenerative disease of the motor system characterized by signs and symptoms of upper and lower motor dysfunction. This results in the presence of focal amyotrophies and pareses affecting voluntary muscles. Patients die after a few years, in most cases by respiratory failure. ALS is the most frequent motor neuron disease; however, its etiology and pathogenesis are only known in fragments. Its genetic basis is only partially understood and major gaps remain in the understanding of its pathogenesis with the basic principle of selective vulnerability and potentially resulting therapeutic consequences.

Entities:  

Mesh:

Year:  2007        PMID: 18038122     DOI: 10.1007/s00115-007-2354-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  18 in total

1.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS.

Authors:  C Münch; R Sedlmeier; T Meyer; V Homberg; A D Sperfeld; A Kurt; J Prudlo; G Peraus; C O Hanemann; G Stumm; A C Ludolph
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

Review 2.  Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis?

Authors:  Ammar Al-Chalabi; P Nigel Leigh
Journal:  Brain       Date:  2005-03       Impact factor: 13.501

3.  135th ENMC International Workshop: nutrition in amyotrophic lateral sclerosis 18-20 of March 2005, Naarden, The Netherlands.

Authors:  A C Ludolph
Journal:  Neuromuscul Disord       Date:  2006-05-15       Impact factor: 4.296

4.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives.

Authors:  P M Andersen; G D Borasio; R Dengler; O Hardiman; K Kollewe; P N Leigh; P-F Pradat; V Silani; B Tomik
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

Review 5.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

6.  Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

Authors:  L Lacomblez; G Bensimon; P N Leigh; P Guillet; V Meininger
Journal:  Lancet       Date:  1996-05-25       Impact factor: 79.321

7.  Increasing mortality from amyotrophic lateral sclerosis in Norway?

Authors:  Y M Seljeseth; S E Vollset; O B Tysnes
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

8.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

9.  Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis.

Authors:  Miriam Butz; Kurt H Wollinsky; Ursula Wiedemuth-Catrinescu; Anne Sperfeld; Susanne Winter; Hans H Mehrkens; Albert C Ludolph; Herbert Schreiber
Journal:  Am J Phys Med Rehabil       Date:  2003-08       Impact factor: 2.159

10.  Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy.

Authors:  M Ben Hamida; F Hentati; C Ben Hamida
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

View more
  2 in total

1.  The economic burden of amyotrophic lateral sclerosis: a systematic review.

Authors:  K Achtert; L Kerkemeyer
Journal:  Eur J Health Econ       Date:  2021-06-18

2.  Implementation of a population-based epidemiological rare disease registry: study protocol of the amyotrophic lateral sclerosis (ALS)--registry Swabia.

Authors:  Gabriele Nagel; Hatice Unal; Angela Rosenbohm; Albert C Ludolph; Dietrich Rothenbacher
Journal:  BMC Neurol       Date:  2013-02-17       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.